发明名称 |
cristal, agente farmacêutico, método para tratar ou evitar doença, uso do cristal, e, método para a produção de um cristal |
摘要 |
<p>Provided is a crystal of (R)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1H-benzimidazole showing an X-ray powder diffraction pattern having characteristic peaks at interplanar spacings (d) of 10.06±0.2, 8.70±0.2, 6.57±0.2, 5.59±0.2 and 4.00±0.2 Angstroms. The present invention provides a stable antiulcer drug superior in the absorbability.</p> |
申请公布号 |
BRPI0909651(A2) |
申请公布日期 |
2015.09.22 |
申请号 |
BR2009PI09651 |
申请日期 |
2009.03.09 |
申请人 |
TAKEDA PHARMACEUTICAL COMPANY |
发明人 |
HIDEO HASHIMOTO;TADASHI URAI |
分类号 |
C07D401/12;A61K31/4439;A61P1/04 |
主分类号 |
C07D401/12 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|